Annual Working Capital
$1.78 B
-$383.51 M-17.73%
31 December 2023
Summary:
BioMarin Pharmaceutical annual working capital is currently $1.78 billion, with the most recent change of -$383.51 million (-17.73%) on 31 December 2023. During the last 3 years, it has fallen by -$70.61 million (-3.82%). BMRN annual working capital is now -17.73% below its all-time high of $2.16 billion, reached on 31 December 2022.BMRN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$2.34 B
+$148.64 M+6.78%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly working capital is currently $2.34 billion, with the most recent change of +$148.64 million (+6.78%) on 30 September 2024. Over the past year, it has increased by +$548.85 million (+30.63%). BMRN quarterly working capital is now -0.51% below its all-time high of $2.35 billion, reached on 30 June 2023.BMRN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.7% | +30.6% |
| 3 y3 years | -3.8% | +30.3% |
| 5 y5 years | +16.1% | +71.4% |
BMRN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.7% | +3.0% | -0.5% | +35.5% |
| 5 y | 5 years | -17.7% | +76.2% | -0.5% | +131.9% |
| alltime | all time | -17.7% | >+9999.0% | -0.5% | >+9999.0% |
BioMarin Pharmaceutical Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.34 B(+6.8%) |
| June 2024 | - | $2.19 B(+15.6%) |
| Mar 2024 | - | $1.90 B(+6.6%) |
| Dec 2023 | $1.78 B(-17.7%) | $1.78 B(-0.7%) |
| Sept 2023 | - | $1.79 B(-23.8%) |
| June 2023 | - | $2.35 B(+4.9%) |
| Mar 2023 | - | $2.24 B(+3.8%) |
| Dec 2022 | $2.16 B(+25.2%) | $2.16 B(+0.0%) |
| Sept 2022 | - | $2.16 B(+5.3%) |
| June 2022 | - | $2.05 B(+7.8%) |
| Mar 2022 | - | $1.90 B(+10.2%) |
| Dec 2021 | $1.73 B(-6.6%) | $1.73 B(-3.8%) |
| Sept 2021 | - | $1.80 B(-6.2%) |
| June 2021 | - | $1.91 B(+3.0%) |
| Mar 2021 | - | $1.86 B(+0.5%) |
| Dec 2020 | $1.85 B(+83.2%) | $1.85 B(-1.8%) |
| Sept 2020 | - | $1.88 B(+2.7%) |
| June 2020 | - | $1.83 B(+41.6%) |
| Mar 2020 | - | $1.30 B(+28.3%) |
| Dec 2019 | $1.01 B(-34.1%) | $1.01 B(-26.1%) |
| Sept 2019 | - | $1.37 B(-0.1%) |
| June 2019 | - | $1.37 B(-3.4%) |
| Mar 2019 | - | $1.42 B(-7.6%) |
| Dec 2018 | $1.53 B(+10.2%) | $1.53 B(-2.3%) |
| Sept 2018 | - | $1.57 B(+6.4%) |
| June 2018 | - | $1.48 B(+0.5%) |
| Mar 2018 | - | $1.47 B(+5.5%) |
| Dec 2017 | $1.39 B(+41.5%) | $1.39 B(-14.8%) |
| Sept 2017 | - | $1.63 B(+50.5%) |
| June 2017 | - | $1.08 B(+7.1%) |
| Mar 2017 | - | $1.01 B(+3.1%) |
| Dec 2016 | $982.48 M(+52.5%) | $982.48 M(-23.8%) |
| Sept 2016 | - | $1.29 B(+73.9%) |
| June 2016 | - | $741.37 M(+22.6%) |
| Mar 2016 | - | $604.78 M(-6.1%) |
| Dec 2015 | $644.18 M(-44.6%) | $644.18 M(-17.9%) |
| Sept 2015 | - | $785.10 M(-9.4%) |
| June 2015 | - | $866.23 M(-28.8%) |
| Mar 2015 | - | $1.22 B(+4.8%) |
| Dec 2014 | $1.16 B(+21.8%) | $1.16 B(+33.4%) |
| Sept 2014 | - | $871.27 M(-17.3%) |
| June 2014 | - | $1.05 B(-3.4%) |
| Mar 2014 | - | $1.09 B(+14.3%) |
| Dec 2013 | $954.15 M(+66.5%) | $954.15 M(+74.8%) |
| Sept 2013 | - | $545.85 M(-5.7%) |
| June 2013 | - | $578.68 M(-0.1%) |
| Mar 2013 | - | $579.02 M(+1.1%) |
| Dec 2012 | $573.00 M(+52.5%) | $573.00 M(-2.0%) |
| Sept 2012 | - | $584.46 M(+4.1%) |
| June 2012 | - | $561.54 M(+42.7%) |
| Mar 2012 | - | $393.58 M(+4.8%) |
| Dec 2011 | $375.68 M | $375.68 M(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $403.77 M(-6.6%) |
| June 2011 | - | $432.08 M(+1.0%) |
| Mar 2011 | - | $427.84 M(+1.8%) |
| Dec 2010 | $420.42 M(+7.9%) | $420.42 M(-9.0%) |
| Sept 2010 | - | $462.09 M(+5.5%) |
| June 2010 | - | $437.98 M(+3.9%) |
| Mar 2010 | - | $421.73 M(+8.3%) |
| Dec 2009 | $389.57 M(-35.9%) | $389.57 M(-14.6%) |
| Sept 2009 | - | $456.20 M(+2.1%) |
| June 2009 | - | $446.95 M(-23.9%) |
| Mar 2009 | - | $587.26 M(-3.3%) |
| Dec 2008 | $607.62 M(+4.3%) | $607.62 M(+5.4%) |
| Sept 2008 | - | $576.28 M(-9.7%) |
| June 2008 | - | $638.39 M(+1.3%) |
| Mar 2008 | - | $630.42 M(+8.2%) |
| Dec 2007 | $582.75 M(+102.2%) | $582.75 M(-1.6%) |
| Sept 2007 | - | $592.17 M(-0.7%) |
| June 2007 | - | $596.39 M(+111.6%) |
| Mar 2007 | - | $281.82 M(-2.2%) |
| Dec 2006 | $288.18 M(+908.5%) | $288.18 M(-2.7%) |
| Sept 2006 | - | $296.14 M(-3.5%) |
| June 2006 | - | $306.80 M(-4.7%) |
| Mar 2006 | - | $321.87 M(+1026.5%) |
| Dec 2005 | $28.57 M(+89.2%) | $28.57 M(-24.7%) |
| Sept 2005 | - | $37.96 M(-969.5%) |
| June 2005 | - | -$4.37 M(-250.3%) |
| Mar 2005 | - | $2.90 M(-80.8%) |
| Dec 2004 | $15.11 M(-92.9%) | $15.11 M(-76.8%) |
| Sept 2004 | - | $64.97 M(-35.2%) |
| June 2004 | - | $100.32 M(-48.2%) |
| Mar 2004 | - | $193.66 M(-8.8%) |
| Dec 2003 | $212.45 M(+186.2%) | $212.45 M(-10.7%) |
| Sept 2003 | - | $237.96 M(-8.4%) |
| June 2003 | - | $259.80 M(+82.9%) |
| Mar 2003 | - | $142.08 M(+91.4%) |
| Dec 2002 | $74.22 M(-42.2%) | $74.22 M(-10.6%) |
| Sept 2002 | - | $83.02 M(-15.1%) |
| June 2002 | - | $97.82 M(-14.2%) |
| Mar 2002 | - | $113.99 M(-11.3%) |
| Dec 2001 | $128.48 M(+241.2%) | $128.48 M(+188.4%) |
| Sept 2001 | - | $44.55 M(-23.8%) |
| June 2001 | - | $58.46 M(+81.4%) |
| Mar 2001 | - | $32.22 M(-14.4%) |
| Dec 2000 | $37.66 M(-38.6%) | $37.66 M(-21.2%) |
| Sept 2000 | - | $47.80 M(-5.7%) |
| June 2000 | - | $50.71 M(-10.8%) |
| Mar 2000 | - | $56.87 M(-7.3%) |
| Dec 1999 | $61.34 M(+467.9%) | $61.34 M(-13.4%) |
| Sept 1999 | - | $70.80 M(+436.4%) |
| June 1999 | - | $13.20 M(+238.5%) |
| Mar 1999 | - | $3.90 M |
| Dec 1998 | $10.80 M | - |
FAQ
- What is BioMarin Pharmaceutical annual working capital?
- What is the all time high annual working capital for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual working capital year-on-year change?
- What is BioMarin Pharmaceutical quarterly working capital?
- What is the all time high quarterly working capital for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly working capital year-on-year change?
What is BioMarin Pharmaceutical annual working capital?
The current annual working capital of BMRN is $1.78 B
What is the all time high annual working capital for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual working capital is $2.16 B
What is BioMarin Pharmaceutical annual working capital year-on-year change?
Over the past year, BMRN annual working capital has changed by -$383.51 M (-17.73%)
What is BioMarin Pharmaceutical quarterly working capital?
The current quarterly working capital of BMRN is $2.34 B
What is the all time high quarterly working capital for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly working capital is $2.35 B
What is BioMarin Pharmaceutical quarterly working capital year-on-year change?
Over the past year, BMRN quarterly working capital has changed by +$548.85 M (+30.63%)